NCT03471520

Brief Summary

There has been some recent evidence to support the use of earplugs and eye masks to prevent delirium, but the existing studies have been small, have not been thoroughly replicated, and have only been conducted with intensive care unit (ICU) patients. Therefore, we propose to conduct a single-arm pilot study for an eventual single-blinded randomized controlled trial designed to assess the efficacy of earplugs and eye masks worn at night for prevention of delirium in a population of general medicine inpatients over the age of 65. The primary outcome will be incidence of delirium as measured by Confusion Assessment Method (CAM). In this pilot study, we will assess feasibility and will not perform any statistical comparisons. In the subsequent randomized controlled trial, we will be comparing the hazard rates on an intention-to-treat basis. Secondary outcomes will be exploratory and include length of stay, cost data, and use of pharmacologic interventions for sleep, delirium, or agitation. There are no physical risks and no cost to the subjects in this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 20, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

August 6, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2018

Completed
Last Updated

November 5, 2021

Status Verified

October 1, 2021

Enrollment Period

4 months

First QC Date

March 14, 2018

Last Update Submit

November 3, 2021

Conditions

Outcome Measures

Primary Outcomes (9)

  • Incidence of delirium

    Will be assessed using the CAM

    The first 5 days of patients' hospitalization

  • Feasibility as measured by number of patients screened

    5 days

  • Feasibility as measured by number of patients ineligible

    5 days

  • Feasibility as measured by number of patients who decline to participate

    5 days

  • Feasibility as measured by number of patients who dropped out of the study

    5 days

  • Feasibility as measured by number of patients who wore the earplugs

    5 days

  • Feasibility as measured by number of patients who wore the eye masks

    5 days

  • Feasibility as measured by number of CAM assessment days

    5 days

  • Feasibility as measured by number of patients who successfully completed the study

    5 days

Study Arms (1)

Earplugs and eye masks

EXPERIMENTAL
Behavioral: Earplugs and eye masks

Interventions

Patients in this study will be given earplugs and eye masks to be worn during sleep

Earplugs and eye masks

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Admitted to General Medicine (units 8100 and 8300 only) from the Duke University Hospital (DUH) Emergency Department
  • Age \>= 65

You may not qualify if:

  • Admitted from outside hospitals, clinics (i.e., direct admissions), or transferred from another department
  • Admitted as "observation" (i.e., expected length of stay \< 2 nights)
  • Admitted \> 24 hours prior to time of enrollment
  • Non-English-speaking patients will be excluded because a language barrier would introduce inaccuracy into the CAM measurement and for feasibility reasons (e.g., availability of translator services)
  • Blind or deaf patients will be excluded because they are unlikely to benefit from the intervention, but sensory-impaired patients will be included
  • Patients lacking decision-making capacity for whom no Legally Authorized Representative (LAR) is available
  • Primary reason for admission "altered mental status", drug withdrawal, stroke, or seizure
  • Patients for whom a withdrawal pathway has been preemptively initiated based on their substance use history (e.g., the alcohol withdrawal pathway order set or other as needed ("PRN") orders for the indication of withdrawal)
  • Delirium present at time of enrollment
  • Glasgow Coma Scale (GCS) \< 10 at time of enrollment
  • Enrolled in this trial during a previous admission (i.e., we will not resample)
  • Enrolled in a separate trial this admission
  • Contraindication to using earplugs or an eye mask (e.g., facial trauma or other safety concern)
  • Significant fall risk per nursing assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Health System

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

DeliriumIatrogenic Disease

Interventions

Ear Protective Devices

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersDisease AttributesPathologic Processes

Intervention Hierarchy (Ancestors)

Personal Protective EquipmentProtective DevicesEquipment and SuppliesProtective ClothingClothingManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Juliessa Pavon, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2018

First Posted

March 20, 2018

Study Start

August 6, 2018

Primary Completion

December 8, 2018

Study Completion

December 8, 2018

Last Updated

November 5, 2021

Record last verified: 2021-10

Locations